Consequently, we demonstrated that simultaneous exposure of vorinostat and the capecitabine metabolite 5′-DFUR in vitro resulted in synergistic antiproliferative and proapoptotic effects in all CRC cell lines examined, independent of p53 status and including cells strongly resistant to 5′-DFUR. Here, TP53 is linked to colorectal carcinoma.